Ambu A/S narrowed earnings guidance for the full-year 2022/23. For the year, the company expected organic revenue growth guidance to 6%-8%, previously 5%-8%; EBIT margin before special items: 5-6% (maintained as per 10 July 2023).
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
132.6 DKK | +0.57% | -3.95% | +26.00% |
May. 15 | Nordic Shares Moved Upward Wednesday; BioArctic Series B Topped Leaders | DJ |
May. 14 | Transcript : Ambu A/S, Q2 2024 Earnings Call, May 14, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+26.00% | 5.05B | |
-3.19% | 105B | |
-4.14% | 67.55B | |
+15.49% | 46.71B | |
-6.00% | 46.39B | |
+4.77% | 40.68B | |
+22.10% | 31.63B | |
+11.75% | 24.35B | |
-8.53% | 23.46B | |
-12.33% | 21.95B |
- Stock Market
- Equities
- AMBU B Stock
- News Ambu A/S
- Ambu A/S Narrows Earnings Guidance for the Full-Year 2022/23